1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Narcolepsy: new trials by email Literature Review of Narcolepsy trials Research Report on Narcolepsy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effectiveness Of The Drug GSK189254 In Treating Patients With Narcolepsy GSK189254 - Narcolepsy | Phase 2 | Terminated | GlaxoSmithKline | 69 | 2006-11-01 | 2017-03-10 |
Disorders of Excessive Somnolence (1) · Dyssomnias (1) · Mental Disorders (1) · Nervous System Diseases (1) · Sleep Disorders, Intrinsic (1) · Sleep Wake Disorders (1)
6-((3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy)-N-methyl-3-pyridinecarboxamide (1)
GlaxoSmithKline (1)
Austria (1) · Finland (1) · Germany (1) · Netherlands (1) · Spain (1) · United Kingdom (1)